531 related articles for article (PubMed ID: 22619887)
1. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
Kongsengdao S; Kritalukkul S
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
[TBL] [Abstract][Full Text] [Related]
2. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
Wu CJ; Shen JH; Chen Y; Lian YJ
Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
[TBL] [Abstract][Full Text] [Related]
4. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
5. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
[TBL] [Abstract][Full Text] [Related]
6. Is it always necessary to apply botulinum toxin into the lower facial muscles in hemifacial spasm?: a randomized, single-blind, crossover trial.
Colakoglu BD; Cakmur R; Uzunel F
Eur Neurol; 2011; 65(5):286-90. PubMed ID: 21502764
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Thussu A; Barman CR; Prabhakar S
Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
[TBL] [Abstract][Full Text] [Related]
9. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A--Dysport and Botox--assuming a ratio of 4:1.
Sampaio C; Ferreira JJ; Simões F; Rosas MJ; Magalhães M; Correia AP; Bastos-Lima A; Martins R; Castro-Caldas A
Mov Disord; 1997 Nov; 12(6):1013-8. PubMed ID: 9399229
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
Quagliato EM; Carelli EF; Viana MA
Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the effects of ice application on patient comfort before and after botulinum toxin type A injections.
Saeliw P; Preechawai P; Aui-aree N
J Med Assoc Thai; 2010 Oct; 93(10):1200-4. PubMed ID: 20973324
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
14. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.
Rieder CR; Schestatsky P; Socal MP; Monte TL; Fricke D; Costa J; Picon PD
Clin Neuropharmacol; 2007; 30(1):39-42. PubMed ID: 17272968
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome correlates with knowledge of disease in hemifacial spasm.
Tan EK; Hameed S; Fook-Chong S; Hussein K; Lum SY; Chan LL
Clin Neurol Neurosurg; 2008 Sep; 110(8):813-7. PubMed ID: 18583029
[TBL] [Abstract][Full Text] [Related]
17. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
Lolekha P; Choolam A; Kulkantrakorn K
Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
Tan EK; Fook-Chong S; Lum SY; Lim E
J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
[TBL] [Abstract][Full Text] [Related]
19. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
Wang J; Zhang X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
[TBL] [Abstract][Full Text] [Related]
20. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs].
Schnider P; Birner P; Moraru E; Auff E
Wien Klin Wochenschr; 1999 Jan; 111(2):59-65. PubMed ID: 10081123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
